Clinical Response to Osimertinib Compared to Other Tyrosine Kinase Inhibitors and Chemotherapy in Non-Small Cell Lung Cancer. (2020). Archives of Clinical and Medical Case Reports, 4(6), 1108-1115. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22422